Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

867044

	registered interest
	date	19/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on negotiating a new Pharmaceutical Price Regulation Scheme.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	133162
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>Informal discussions have already begun with industry regarding future medicines pricing arrangements. Formal negotiations will begin during 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/03/2018 11:48:24 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

873628

	registered interest
	date	28/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Spondyloarthritis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the monitoring of individual Quality Statement measures in the NICE Quality Standard on Spondyloarthritis, to be published in June 2018.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	134742
	answer	answer is ministerial correction date of answer 17/04/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) quality standards are concise sets of statements designed to drive quality improvements within a particular area of care and cover the National Health Service, public health and social care. They are derived from the best available evidence, normally NICE guidance but also other sources of NICE-accredited guidance, and are developed by NICE in collaboration with health and social care professionals, their partners and service users. The Department does not have any arrangements for monitoring the uptake of NICE quality standards centrally as they are not mandatory, although health and care commissioners are expected to take them fully into account.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/04/2018 14:04:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

873629

	registered interest
	date	28/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Arthritis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the Rheumatoid and Early Inflammatory Arthritis Annual Report; and whether that report will include additional data collection for spondyloarthritis patients.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	134743
	answer	answer is ministerial correction date of answer 17/04/2018 answer text <p>In August 2017, a new three year Rheumatoid and Early Inflammatory Arthritis Audit was commissioned by the Healthcare Quality Improvement Partnership (HQIP). HQIP manages the National Clinical Audit and Patient Outcomes Programme on behalf of NHS England.</p><p> </p><p>The British Society for Rheumatology was awarded the contract to run the audit, which will assess the care provided by rheumatology services in England and Wales, and the health outcomes this achieves for people living with inflammatory arthritis conditions, including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.</p><p> </p><p>Building on the previous audit, which ran from 2014-16, it will provide more focused and precise data and employ real-time feedback to support local quality improvement. The audit is expected to launch in May this year, with first reports expected in the autumn of 2019. More information can be found at the following link:</p><p> </p><p><a href="http://www.rheumatology.org.uk/Knowledge/Excellence/Audits" target="_blank">www.rheumatology.org.uk/Knowledge/Excellence/Audits</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/04/2018 13:59:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

882155

	registered interest
	date	13/04/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timetable for negotiations on the new pharmaceutical price regulation scheme is; and if he will make a statement.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	135214
	answer	answer is ministerial correction date of answer 19/04/2018 answer text <p>Informal discussions have already begun with industry regarding future medicines pricing arrangements. Formal negotiations will begin shortly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/04/2018 11:28:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

964649

	registered interest
	date	03/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on establishing an Accelerated Access Collaborative to manage the new accelerated access pathway.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	169360
	answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>The Accelerated Access Collaborative (AAC) has been successfully established, meeting for the first time in January 2018 and agreeing terms of reference and ways of working. Lord Darzi is the new chair of the AAC, replacing Sir Andrew Witty, who stood down to avoid any conflict of interest with his new role as CEO of Optum. We expect that the Accelerated Access Pathway will launch at the next meeting of the AAC, which will be in the autumn.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 14:37:19 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

964650

	registered interest
	date	03/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the accelerated access pathway is planned to begin designating breakthrough products.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	169361
	answer	answer is ministerial correction date of answer 11/09/2018 answer text <p>The Accelerated Access Collaborative will meet this autumn to launch the Accelerated Access Pathway and the first group of products will be part of their discussions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2018 14:35:39 answering member 4067 label Biography information for Steve Brine
	tabling member	4109 label Biography information for Jeremy Lefroy

1149004

	registered interest
	date	14/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to mental health support for people with type 1 diabetes.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	248
	answer	answer is ministerial correction date of answer 17/10/2019 answer text <p>The NHS Long Term Plan committed to increasing the provision of mental health support for all patients who require it. The importance of addressing the mental health needs of people with diabetes is recognised and further work is underway to consider the most effective routes for supporting this as part of the future development of services.</p><p> </p><p>On 21 March 2018, NHS England and NHS Improvement, along with the National Collaboration Institute for Mental Health, published ‘The Improving Access to Psychotherapy Therapy (IAPT) Pathway for People with Long-term Physical Health Conditions and Medically Unexplained Symptoms’. The guidance outlines the IAPT pathway, and accompanying benchmarks, to support the national expansion of IAPT services for adults with long term conditions and medically unexplained symptoms.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 17/10/2019 15:41:08 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	4109 label Biography information for Jeremy Lefroy

1166957

	registered interest
	date	29/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	What recent discussions he has had with the Secretary of State for Environment, Food and Rural Affairs on vaccine research to tackle antimicrobial resistance.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	900208
	answer	answer is ministerial correction date of answer 29/10/2019 answer text <p>My Right Honourable friend and I recognise the importance of vaccination in tackling antimicrobial resistance (or AMR). Our AMR national action plan, developed across Government, includes commitments to optimise use of vaccines in humans and animals, and stimulate vaccine research and development.</p><p>A cross-departmental Delivery Board, co-chaired by my Department and the Department for Environment, Food and Rural Affairs, will drive and oversee delivery of this work and met for the first time this month.</p> answering member constituency West Suffolk answering member printed Matt Hancock question first answered 29/10/2019 16:46:31 answering member 4070 label Biography information for Matt Hancock
	tabling member	4109 label Biography information for Jeremy Lefroy

1149005

	registered interest
	date	14/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Nurses: Training
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reinstating the nursing bursary.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	249
	answer	answer is ministerial correction date of answer 17/10/2019 answer text <p>The education funding reforms unlocked the cap which constrained the number of pre-registration nurse training places allowing more students to gain access to nurse degree training courses. Eligible pre-registration nursing students now receive at least 25% more support than under the National Health Service bursary system through tuition fee loans and living cost support from the Student Loans Company.</p><p>Additionally, to support pre-registration nursing students whilst attending the clinical placement element of their courses, the Government introduced a Learning Support Fund. Eligible loan funded students can apply for non means tested and non-repayable annual payments of £1,000 for child dependents allowance, reimbursement of all clinical placement travel costs above their usual daily travel and exceptional hardship payments of up to £3,000. These are in addition to the allowances paid by the Student Loans Company.</p><p>On 19 September 2019 the Universities and College Admission Services (UCAS) published data on full-time undergraduate applicants to nursing and midwifery courses. The data shows that there are 21,590 placed applicants on nursing and midwifery courses at English providers. This is 4% higher than the same point in 2018 when there were 20,690 place applicants.</p><p>UCAS will publish further data in December 2019.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 17/10/2019 09:42:06 answering member 4362 label Biography information for Edward Argar
	tabling member	4109 label Biography information for Jeremy Lefroy

1128283

	registered interest
	date	22/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hospitals: Data Protection
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of subject access requests made to NHS hospitals were responded to within the correct timescale since the General Data Protection Regulation came into force; and what steps he is taking to reduce the volume of those requests.
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	uin	257545
	answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>We do not currently collect this data. Individual trusts may hold this data but are not required to share this with the Government. There are currently no steps being taken to reduce the volume of these requests.</p><p><strong> </strong></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 07/06/2019 13:20:16 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4109 label Biography information for Jeremy Lefroy